About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of LY3848575 in Healthy Participants | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05727072

A Study of LY3848575 in Healthy Participants

The main purpose of this study is to evaluate the safety and tolerability of LY3848575 when administered either intravenously or subcutaneously in single ascending or multiple doses in healthy non-Jap...

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Participants who are overtly healthy as determined by medical evaluation
•Have body weight of at least 50 kilograms (kg) for males and 40 kg for females, and body mass index of 18 to 30 kilograms per meter squared (kg/m²), inclusive
•For cohorts with Japanese participants: To qualify as a participant of the first-generation Japanese origin, the participant, the participant's biological parents, and all of the participant's biological grandparents must be of exclusive Japanese descent and born in Japan

Exclusion Criteria

•Are currently enrolled in any other clinical study involving an investigational product (IP) or any other type of medical research judged not to be scientifically or medically compatible with this study.
•Have participated, within the last 3 months, in a clinical study involving an IP.

Related studies

Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched

RECRUITINGPhase 1

A Study of Eltrekibart (LY3041658) in Healthy Participants

NCT07545590 · Healthy

RECRUITINGPhase 1

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

NCT07258836 · Neoplasms, Healthy

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT00090662 · Healthy Volunteer

Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities

NCT07059858 · Intellectual Disability, Healthy Subjects

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 4, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment64

Start dateFeb 2023

Last updatedApr 4, 2024

Condition

Locations shown

Anaheim Clinical Trials, LLC

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 4, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions